Stevenage, United Kingdom

Richard Anthony Henson

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Anthony Henson. Retrieved from https://idiyas.com/inventor/richard-anthony-henson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard Anthony Henson: Innovator in Pharmaceutical Chemistry

Introduction

Richard Anthony Henson is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of PPAR-ligands. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.

Latest Patents

Henson holds a patent for a "Process for preparing a thiazole PPAR-ligand and polymorphs thereof." This patent describes a method of preparing a compound of formula (I), along with pharmaceutically acceptable salts and solvates. The patent also discloses polymorphs of this compound and their use as PPAR ligands, highlighting the potential for new therapeutic avenues.

Career Highlights

Richard Anthony Henson is associated with Glaxo Group Limited, a leading company in the pharmaceutical industry. His role at Glaxo has allowed him to work on cutting-edge research and development projects, contributing to advancements in drug formulation and delivery.

Collaborations

Throughout his career, Henson has collaborated with esteemed colleagues such as Thierry Boyer and Caroline Jane Day. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Richard Anthony Henson's contributions to pharmaceutical chemistry and his innovative patent work exemplify the impact of dedicated inventors in the industry. His ongoing efforts continue to shape the future of drug development and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…